BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marquès JM, Belza I, Holtmann B, Pennica D, Prieto J, Bustos M. Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. Hepatology 2007;45:639-48. [PMID: 17326158 DOI: 10.1002/hep.21508] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Soares ROS, Losada DM, Jordani MC, Évora P, Castro-E-Silva O. Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies. Int J Mol Sci 2019;20:E5034. [PMID: 31614478 DOI: 10.3390/ijms20205034] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 16.7] [Reference Citation Analysis]
2 Garcia-cenador MB, Lorenzo-gomez MF, Herrero-payo JJ, Ruiz J, Perez de Obanos MP, Pascual J, Lopez-novoa JM, Garcia-criado FJ. Cardiotrophin-1 Administration Protects from Ischemia-Reperfusion Renal Injury and Inflammation. Transplantation 2013;96:1034-42. [DOI: 10.1097/tp.0b013e3182a74db4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? J Mol Cell Cardiol. 2009;47:32-40. [PMID: 19344728 DOI: 10.1016/j.yjmcc.2009.03.019] [Cited by in Crossref: 216] [Cited by in F6Publishing: 211] [Article Influence: 16.6] [Reference Citation Analysis]
4 Quiros Y, Sánchez-gonzález PD, López-hernández FJ, Morales AI, López-novoa JM. Cardiotrophin-1 Administration Prevents the Renal Toxicity of Iodinated Contrast Media in Rats. Toxicological Sciences 2013;132:493-501. [DOI: 10.1093/toxsci/kft007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
5 Aguilar-Melero P, Luque A, Machuca MM, Pérez de Obanos MP, Navarrete R, Rodríguez-García IC, Briceño J, Iñiguez M, Ruiz J, Prieto J, de la Mata M, Gomez-Villamandos RJ, Muntane J, López-Cillero P. Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. J Surg Res 2013;181:e83-91. [PMID: 22906559 DOI: 10.1016/j.jss.2012.07.046] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
6 Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. J Hepatol 2014;60:1017-25. [PMID: 24362075 DOI: 10.1016/j.jhep.2013.12.012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
7 Farran I, Río-Manterola F, Iñiguez M, Gárate S, Prieto J, Mingo-Castel AM. High-density seedling expression system for the production of bioactive human cardiotrophin-1, a potential therapeutic cytokine, in transgenic tobacco chloroplasts. Plant Biotechnol J 2008;6:516-27. [PMID: 18384506 DOI: 10.1111/j.1467-7652.2008.00334.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
8 Rickenbacher A, Graf R, Clavien PA. The way to safer liver resection in cirrhotic patients: is Cardiotrophin-1 the future miracle drug? Liver Int 2008;28:589-91. [PMID: 18433388 DOI: 10.1111/j.1478-3231.2008.01751.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Moreno-Aliaga MJ, Romero-Lozano MA, Castaño D, Prieto J, Bustos M. Role of cardiotrophin-1 in obesity and insulin resistance. Adipocyte 2012;1:112-5. [PMID: 23700521 DOI: 10.4161/adip.19696] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
10 Sánchez-Garrido AI, Prieto-Vicente V, Blanco-Gozalo V, Arévalo M, Quiros Y, López-Montañés D, López-Hernández FJ, Rodríguez-Pérez A, López-Novoa JM. Preventive Effect of Cardiotrophin-1 Administration before DSS-Induced Ulcerative Colitis in Mice. J Clin Med 2019;8:E2086. [PMID: 31805674 DOI: 10.3390/jcm8122086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Fukuhara S, Leitman IM. Cardiotrophin-1, an antiinflammatory cytokine; is there a therapeutic role in orthotopic liver transplantation? J Surg Res 2013;185:e63-5. [PMID: 22940036 DOI: 10.1016/j.jss.2012.08.003] [Reference Citation Analysis]
12 Asrih M, Mach F, Quercioli A, Dallegri F, Montecucco F. Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity. Mediators Inflamm 2013;2013:370715. [PMID: 23690661 DOI: 10.1155/2013/370715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Prieto-Vicente V, Sánchez-Garrido AI, Blanco-Gozalo V, Arévalo M, García-Sánchez E, López-Montañés D, Quiros Y, López-Hernández FJ, Rodríguez-Pérez A, López-Novoa JM. Cardiotrophin-1 attenuates experimental colitis in mice. Clin Sci (Lond) 2018;132:985-1001. [PMID: 29572384 DOI: 10.1042/CS20171513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Carneros D, Medina-Gómez G, Giralt M, León-Camacho M, Campbell M, Moreno-Aliaga MJ, Villarroya F, Bustos M. Cardiotrophin-1 contributes to metabolic adaptations through the regulation of lipid metabolism and to the fasting-induced fatty acid mobilization. FASEB J 2020;34:15875-87. [PMID: 33047392 DOI: 10.1096/fj.202000109R] [Reference Citation Analysis]
15 Donthamsetty S, Mars WM, Orr A, Wu C, Michalopoulos GK. Protection against Fas-induced fulminant hepatic failure in liver specific integrin linked kinase knockout mice. Comp Hepatol 2011;10:11. [PMID: 22104495 DOI: 10.1186/1476-5926-10-11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
16 Stephens J, Ravussin E, White U. The Expression of Adipose Tissue-Derived Cardiotrophin-1 in Humans with Obesity. Biology (Basel) 2019;8:E24. [PMID: 31013924 DOI: 10.3390/biology8020024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Tuñon MJ, San Miguel B, Crespo I, Riezu-Boj JI, Larrea E, Alvarez M, González I, Bustos M, González-Gallego J, Prieto J. Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin. J Virol 2011;85:13124-32. [PMID: 21976657 DOI: 10.1128/JVI.05725-11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Calabrò P, Limongelli G, Riegler L, Maddaloni V, Palmieri R, Golia E, Roselli T, Masarone D, Pacileo G, Golino P, Calabrò R. Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. Journal of Molecular and Cellular Cardiology 2009;46:142-8. [DOI: 10.1016/j.yjmcc.2008.11.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
19 Herencia C, Almadén Y, Ferrín G, Martínez-romero R, de la Mata M, Ciria R, Briceño FJ, Muñoz-castañeda JR. Cardiotrophin-1 decreases liver apoptosis through calpastatin induction. Journal of Surgical Research 2015;193:119-25. [DOI: 10.1016/j.jss.2014.06.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Stejskal D, Ruzicka V. Cardiotrophin-1. Review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008;152:9-19. [PMID: 18795069 DOI: 10.5507/bp.2008.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang H, Lafdil F, Kong X, Gao B. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci. 2011;7:536-550. [PMID: 21552420 DOI: 10.7150/ijbs.7.536] [Cited by in Crossref: 164] [Cited by in F6Publishing: 169] [Article Influence: 14.9] [Reference Citation Analysis]
22 Uçeyler N, Biko L, Sommer C. MDL-28170 has no analgesic effect on CCI induced neuropathic pain in mice. Molecules 2010;15:3038-47. [PMID: 20657463 DOI: 10.3390/molecules15053038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
23 Casales E, Aranda A, Quetglas JI, Ruiz-Guillen M, Rodriguez-Madoz JR, Prieto J, Smerdou C. A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vector. N Biotechnol 2010;27:138-48. [PMID: 20188220 DOI: 10.1016/j.nbt.2010.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
24 Tian Y, Ruan X, Laurikka J, Laine S, Tarkka M, Wei M. The human heart releases cardiotrophin-1after coronary artery bypass grafting with cardiopulmonary bypass. Scandinavian Cardiovascular Journal 2011;45:252-6. [DOI: 10.3109/14017431.2011.585659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Moreno-Aliaga MJ, Pérez-Echarri N, Marcos-Gómez B, Larequi E, Gil-Bea FJ, Viollet B, Gimenez I, Martínez JA, Prieto J, Bustos M. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism. Cell Metab 2011;14:242-53. [PMID: 21803294 DOI: 10.1016/j.cmet.2011.05.013] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 7.3] [Reference Citation Analysis]
26 López-Yoldi M, Moreno-Aliaga MJ, Bustos M. Cardiotrophin-1: A multifaceted cytokine. Cytokine Growth Factor Rev 2015;26:523-32. [PMID: 26188636 DOI: 10.1016/j.cytogfr.2015.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
27 Bustos M, Dubrot J, Martinez-Anso E, Larequi E, Castaño D, Palazon A, Belza I, Sanmamed MF, Perez-Gracia JL, Ortiz de Solorzano C, Alfaro C, Melero I. Cardiotrophin-1 determines liver engraftment of syngenic colon carcinoma cells through an immune system-mediated mechanism. Oncoimmunology 2012;1:1527-36. [PMID: 23264899 DOI: 10.4161/onci.22504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Kurt OK, Tosun M, Talay F. Serum cardiotrophin-1 and IL-6 levels in patients with obstructive sleep apnea syndrome. Inflammation 2013;36:1344-7. [PMID: 23783568 DOI: 10.1007/s10753-013-9673-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
29 Segura V, Medina-Aunon JA, Guruceaga E, Gharbi SI, González-Tejedo C, Sánchez del Pino MM, Canals F, Fuentes M, Casal JI, Martínez-Bartolomé S, Elortza F, Mato JM, Arizmendi JM, Abian J, Oliveira E, Gil C, Vivanco F, Blanco F, Albar JP, Corrales FJ. Spanish human proteome project: dissection of chromosome 16. J Proteome Res 2013;12:112-22. [PMID: 23234512 DOI: 10.1021/pr300898u] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
30 Song J, Zhang Y, Yao A, Yu Y, Hua Z, Pu L, Li G, Li X, Zhang F, Sheng G, Wang X. Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transplant International 2008;21:372-83. [DOI: 10.1111/j.1432-2277.2007.00616.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
31 Horiguchi N, Lafdil F, Miller AM, Park O, Wang H, Rajesh M, Mukhopadhyay P, Fu XY, Pacher P, Gao B. Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. Hepatology. 2010;51:1724-1734. [PMID: 20196117 DOI: 10.1002/hep.23532] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]